Unique ID issued by UMIN | UMIN000016431 |
---|---|
Receipt number | R000019080 |
Scientific Title | Analysis of gene polymorphism in hepatocellular carcinoma patients treated with sorafenib therapy |
Date of disclosure of the study information | 2015/02/06 |
Last modified on | 2023/08/16 11:37:44 |
Analysis of gene polymorphism in hepatocellular carcinoma patients treated with sorafenib therapy
AGHCs
Analysis of gene polymorphism in hepatocellular carcinoma patients treated with sorafenib therapy
AGHCs
Japan |
Heoatocellular carcinoma
Hepato-biliary-pancreatic medicine |
Malignancy
YES
We investigated the relationship with side effects and prognosis according to gene polymorphism in hepatocellular carcinoma patients treated with sorafenib.
Safety,Efficacy
Relationship between side effects and gene polymorphism
Relationship between prognosis and gene polymorphism
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
sorafenib therapy
20 | years-old | <= |
Not applicable |
Male and Female
1. Clinical diagnosed hepatocellular carcinoma patients treated with sorafenib therapy, discontinued sorafenib therapy, or intended to treat with sorafenib therapy
2. Extrahepatic metastasis is no object.
3. Child-Pugh class A-B(7)
4. Good reserved function of main organs (bone marrow, kidney, and heart)
(1) WBC >/= 2000/mm3
(2) Plt >/= 5x104/mm3
(3) Hb >/= 8.0g/dL
(4) creatinine < 2mg/dL
(5) Heart function except exclusion criteria
5. Informed consentwas obtained.
1. Following serous comlicating diseases, except for chronic hepatitis and liver cirrhosis:
a) Renal failure with blood or peritoneal dialysis
b) Heart failure >/= NYHA class III, serious ischemic herat disease, and serious arhythmia
c) uncontrolled hypertension
d) brain tumors
2. Past or present history of malignant tumors except for HCC
3. Past history of allergy in iodine or contrast agent
4. Inadequate patient judged by a doctor
150
1st name | Takahiro |
Middle name | |
Last name | Yamasaki |
Yamaguchi University Graduate School of Medicine
Department of Oncology and Laboratory Medicine
755-8505
1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan
0836-22-2336
t.yama@yamaguchi-u.ac.jp
1st name | Saeki |
Middle name | |
Last name | Issei |
Yamaguchi University Graduate School of Medicine
Department of Gastroenterology and Hepatology
755-8505
1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan
0836-22-2241
issaeki@yamaguchi-u.ac.jp
Yamaguchi University Hospital
None
Self funding
Center For Clinical Research.Yamaguchi University Hospital
1-1-1 Minami Kogushi, Ube, Yamaguchi 755-8505, Japan
0836-22-2428
me223@yamaguchi-u.ac.jp
NO
2015 | Year | 02 | Month | 06 | Day |
Unpublished
Open public recruiting
2014 | Year | 10 | Month | 31 | Day |
2014 | Year | 11 | Month | 28 | Day |
2015 | Year | 02 | Month | 06 | Day |
2024 | Year | 03 | Month | 31 | Day |
2015 | Year | 02 | Month | 03 | Day |
2023 | Year | 08 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019080
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |